Orfadin Oral Suspension (nitisinone)

pCPA File Number: 21158
Negotiation Status:
Concluded without agreement
Indication(s):
Hereditary Tyrosinemia Type 1
Sponsor/Manufacturer:
Sobi Canada Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: